| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/13506129.2012.702703 |
| P2093 | author name string | Robert Kisilevsky | |
| P2860 | cites work | Acute-phase serum amyloid A: perspectives on its physiological and pathological roles | Q28259372 |
| Impact of serum amyloid A on high density lipoprotein composition and levels | Q34187954 | ||
| ATP binding cassette G1-dependent cholesterol efflux during inflammation | Q34503409 | ||
| The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. | Q39571798 | ||
| Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. | Q43141414 | ||
| Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency | Q43154533 | ||
| Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency | Q46662065 | ||
| The path of murine serum amyloid a through peritoneal macrophages | Q58257518 | ||
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 165-166 | |
| P577 | publication date | 2012-06-28 | |
| P1433 | published in | Amyloid | Q4749545 |
| P1476 | title | Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply | |
| P478 | volume | 19 |
Search more.